MedPath

RANOLAZINA TEVA 500 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG

RANOLAZINA TEVA 500 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG

Commercialized
Register Number

89227

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jan 9, 2024

Dosage Form

COMPRIMIDO DE LIBERACIÓN PROLONGADA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89227
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RANOLAZINAActive
Quantity: 500 mg
Name: RANOLAZINA

ATC CLASSIFICATION (3)

C01E
C01EB
C01EB18

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.